|
|
Article: Taxus fails to outperform CABG in SYNTAX clinicals.
- Article from:
- Medical Device Daily
- Article date:
- September 3, 2008
CopyrightCOPYRIGHT 2008 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
European Society of Cardiology Congress: It's 'damage control' time for DES supporters
Taxus fails to outperform CABG in SYNTAX clinicals
By JOHN BROSKY
Medical Device Daily European Editor
MUNICH, Germany -- It was supposed to be a stunning victory for drug-eluting stents (DES).
Instead, the release of the SYNTAX study here during the annual congress of the European Society of Cardiology (ESC; Sophia Antipolis, France) has left some 24,000 participating cardiologists scratching their heads over the conclusions and sent the supporters of DES scrambling for damage control.
In the wake of the devastating reports in ...